Your browser doesn't support javascript.
loading
Literature meta-analysis about the efficacy of re-challenge with PD-1 and PD-L1 inhibitors in cancer patients.
Gobbini, Elisa; Charles, Julie; Toffart, Anne-Claire; Leccia, Marie-Thérèse; Moro-Sibilot, Denis; Levra, Matteo Giaj.
Affiliation
  • Gobbini E; CHU de Grenoble, Thoracic Oncology Unit, Grenoble, France; Cancer Research Center Lyon, Centre Léon-Bérard, Lyon, France. Electronic address: elisa.gobbini@hotmail.it.
  • Charles J; Institute for Advanced Biosciences, Université Grenoble Alpes/INSERM U1209/CNRS UMR 5309 Joint Research Center, Grenoble, France; Grenoble Alpes University Hospital, Dermatology Department, Grenoble, France.
  • Toffart AC; CHU de Grenoble, Thoracic Oncology Unit, Grenoble, France.
  • Leccia MT; Grenoble Alpes University Hospital, Dermatology Department, Grenoble, France.
  • Moro-Sibilot D; CHU de Grenoble, Thoracic Oncology Unit, Grenoble, France.
  • Levra MG; CHU de Grenoble, Thoracic Oncology Unit, Grenoble, France.
Bull Cancer ; 107(11): 1098-1107, 2020 Nov.
Article in En | MEDLINE | ID: mdl-33032816

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Programmed Cell Death 1 Receptor / Antineoplastic Agents, Immunological / Neoplasms Type of study: Guideline / Systematic_reviews Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Bull Cancer Year: 2020 Document type: Article Country of publication: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: B7-H1 Antigen / Programmed Cell Death 1 Receptor / Antineoplastic Agents, Immunological / Neoplasms Type of study: Guideline / Systematic_reviews Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Bull Cancer Year: 2020 Document type: Article Country of publication: Francia